Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.

This study has been completed.
Information provided by:
Melbourne Health Identifier:
First received: November 17, 2005
Last updated: April 10, 2017
Last verified: April 2015

The purpose of this study is to determine if naso-jejunal feeding (feeding beyond the stomach) improves the efficacy of enteral feeding (feeding into the gut) in critically ill patients.

The study hypothesis is that in patients who fail to establish enteral feeding via the nasogastric route, introduction of nasojejunal feeding will lead to more effective enteral feeding than the current regime involving staged introduction of promotility agents.

Condition Intervention
Critically Ill
Procedure: Nasojejunal feeding

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.

Further study details as provided by Melbourne Health:

Primary Outcome Measures:
  • Efficacy of feeding [ Time Frame: participants will be followed until death, discharge from ICU, commencement of oral or parental nutrition or 28 days post ICU admission ]

Secondary Outcome Measures:
  • 1. To determine the incidence of complications with enteral feeding via nasogastric and nasojejunal routes. [ Time Frame: participants will be followed until death, discharge from ICU, commencement of parental or oral nutrition or 28 days post ICU admission. ]
  • 2. To assess the efficacy of current strategies for optimising enteral feeding efficacy. [ Time Frame: participants will be followed until death, discharge from ICU commencement of oral or parental nutrition,or 28 days post ICU admission. ]

Enrollment: 50
Study Start Date: May 2003
Study Completion Date: July 2005
Arms Assigned Interventions
No Intervention: Standard Care
Patients will receive enteral nutrition via a nasogastric tube as per standard feeding regime
Active Comparator: Nasojejunal Arm
Patient will receive feeding via a nasojejunal feeding tube
Procedure: Nasojejunal feeding

Detailed Description:

The study examines the area of enteral feeding in critically ill patients. Current standard enteral feeding practice is via a nasogastric with the addition of promotility agents for patients who fail to absorb their enteral nutrition.

This study compares the efficacy of nasojejunal feeding feeding with nasogastric enteral feeding with the addition of promotility agents.

The duration of feeding will be determined by the patients nutritional requirements and their general condition. However the data will be collected for duration of enteral feeding, 28 days or ICU discharge whichever occurs first.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Adult patients (18years or over) admitted to the ICU with an expected stay of more than 48 hours.
  2. Patients commenced on enteral feeding via a nasogastric tube who fail to tolerate gastric feeding due to excessive gastric aspirate volumes.
  3. Patients who consent or if the patient is incompetent, the next of kin, who consent, to inclusion in the study.

Exclusion Criteria:

  1. patients less than 18 years of age.
  2. Patients with known allergy to promotility agents, metoclopramide or erythromycin.
  3. Patients with a contra indication to nasojejunal feeding. -
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00256048

Australia, Victoria
Intensive Care Unit, Royal Melbourne Hospital, Grattan Street
Parkville, Victoria, Australia, 3050
Sponsors and Collaborators
Melbourne Health
Principal Investigator: Megan Robertson Intensive Care Unit, Royal Melbourne Hospital
  More Information

Responsible Party: Melbourne Health Identifier: NCT00256048     History of Changes
Other Study ID Numbers: 2002.228
Study First Received: November 17, 2005
Last Updated: April 10, 2017

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes processed this record on May 23, 2017